JP4688298B2 - 抗不安特性を有する乳酸菌及びその使用 - Google Patents

抗不安特性を有する乳酸菌及びその使用 Download PDF

Info

Publication number
JP4688298B2
JP4688298B2 JP2000616727A JP2000616727A JP4688298B2 JP 4688298 B2 JP4688298 B2 JP 4688298B2 JP 2000616727 A JP2000616727 A JP 2000616727A JP 2000616727 A JP2000616727 A JP 2000616727A JP 4688298 B2 JP4688298 B2 JP 4688298B2
Authority
JP
Japan
Prior art keywords
strain
cncm
deposited
lactic acid
february
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000616727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002544146A (ja
JP2002544146A5 (cg-RX-API-DMAC10.html
Inventor
アントワーヌ，ジャン−ミシェル
ケユラ，シャンタル
ドジヴリ，マリ−クリスティーヌ
ラトジ，クリスティアン
ポステール，エリック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Publication of JP2002544146A publication Critical patent/JP2002544146A/ja
Publication of JP2002544146A5 publication Critical patent/JP2002544146A5/ja
Application granted granted Critical
Publication of JP4688298B2 publication Critical patent/JP4688298B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000616727A 1999-05-06 2000-05-05 抗不安特性を有する乳酸菌及びその使用 Expired - Lifetime JP4688298B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905760A FR2793257B1 (fr) 1999-05-06 1999-05-06 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FR99/05760 1999-05-06
PCT/FR2000/001238 WO2000067696A2 (fr) 1999-05-06 2000-05-05 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Publications (3)

Publication Number Publication Date
JP2002544146A JP2002544146A (ja) 2002-12-24
JP2002544146A5 JP2002544146A5 (cg-RX-API-DMAC10.html) 2007-06-07
JP4688298B2 true JP4688298B2 (ja) 2011-05-25

Family

ID=9545277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000616727A Expired - Lifetime JP4688298B2 (ja) 1999-05-06 2000-05-05 抗不安特性を有する乳酸菌及びその使用

Country Status (13)

Country Link
US (1) US6541027B1 (cg-RX-API-DMAC10.html)
EP (1) EP1175221B1 (cg-RX-API-DMAC10.html)
JP (1) JP4688298B2 (cg-RX-API-DMAC10.html)
AT (1) ATE362765T1 (cg-RX-API-DMAC10.html)
AU (1) AU4414400A (cg-RX-API-DMAC10.html)
CA (1) CA2373112C (cg-RX-API-DMAC10.html)
DE (1) DE60034940T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175221T3 (cg-RX-API-DMAC10.html)
ES (1) ES2287011T3 (cg-RX-API-DMAC10.html)
FR (1) FR2793257B1 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011248A (cg-RX-API-DMAC10.html)
PT (1) PT1175221E (cg-RX-API-DMAC10.html)
WO (1) WO2000067696A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444203B2 (en) * 1999-12-20 2002-09-03 Compagnie Gervais Danone Administering bacteria to improve sleep
FR2811333B1 (fr) * 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
JP3648233B2 (ja) * 2003-04-08 2005-05-18 明治飼糧株式会社 飼料組成物
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
FR2895877B1 (fr) * 2006-01-06 2012-06-22 Gervais Danone Sa Poudre de lait fermente ou yaourt a haute densite en ferments lactiques
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
US20130302322A1 (en) 2012-05-11 2013-11-14 Five Prime Therapeutics, Inc. Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
US20150284675A1 (en) * 2012-10-25 2015-10-08 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
SG11201506640TA (en) * 2013-02-27 2015-09-29 Meiji Co Ltd Anti-stress agent
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
US11135181B2 (en) 2014-10-28 2021-10-05 Medlab Ip Pty Ltd Treatment for depression and depressive disorders
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2020170776A1 (ja) * 2019-02-19 2020-08-27 株式会社ヤクルト本社 乳酸菌及び／又はビフィドバクテリウム属細菌培養物の製造方法
JP7536504B2 (ja) * 2019-05-31 2024-08-20 株式会社明治 抑うつ症状改善剤及びそれを含む組成物
US12635861B2 (en) * 2022-05-25 2026-05-26 Boston Scientific Scimed, Inc. Attachment mechanism for using an endoscope with a surgical robot

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌

Also Published As

Publication number Publication date
CA2373112C (fr) 2012-08-07
DE60034940D1 (de) 2007-07-05
CA2373112A1 (fr) 2000-11-16
PT1175221E (pt) 2007-09-04
DE60034940T2 (de) 2008-01-24
FR2793257B1 (fr) 2001-07-27
ATE362765T1 (de) 2007-06-15
DK1175221T3 (da) 2007-10-08
ES2287011T3 (es) 2007-12-16
FR2793257A1 (fr) 2000-11-10
JP2002544146A (ja) 2002-12-24
EP1175221B1 (fr) 2007-05-23
US6541027B1 (en) 2003-04-01
MXPA01011248A (es) 2002-11-04
AU4414400A (en) 2000-11-21
WO2000067696A2 (fr) 2000-11-16
EP1175221A2 (fr) 2002-01-30
WO2000067696A3 (fr) 2001-03-22

Similar Documents

Publication Publication Date Title
Aggarwal et al. Probiotics and their effects on metabolic diseases: an update
Taverniti et al. Health-promoting properties of Lactobacillus helveticus
JP5686680B2 (ja) 乳酸菌発酵によるカゼイン由来ペプチドの製造方法
Yahya et al. Antihypertensive effect of fermented skim camel (Camelus dromedarius) milk on spontaneously hypertensive rats
US6541027B1 (en) Lactic acid bacteria with anxiolytic properties and uses thereof
HRP20020378A2 (en) Lactobacillus helvetius producing antihypertensive di- and tripeptides
US20100203026A1 (en) Probiotics for inducing satiety and/or satiation
WO2008004794A1 (en) New functional fermented milk (yogurt) for use in dieting
CN111212575A (zh) 肌肉增量用组合物
DE60028613T2 (de) Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien
CN117917475B (zh) 一种调节肠道菌群的植物乳植杆菌p16及其应用、产品和方法
CN104381440B (zh) 发酵乳杆菌Lactobacillus fermentum strain Lee工作发酵剂制品及其预防便秘保健用途
US10307445B2 (en) Bacterial strains having an outstanding ability to produce menaquinone
US20120328735A1 (en) Process for preparing casein-derived peptides by fermentation of lactic acid bacteria
Pato et al. Hypocholesterolemic effect of indigenous dadih lactic acid bacteria by deconjugation of bile salts
US20100158882A1 (en) Immunomodulating probiotic lactic acid bacteria
CN104651271B (zh) 干酪乳杆菌Lactobacillus casei strain Qian工作发酵剂制品及其肠道调节保健用途
CN104651272B (zh) 干酪乳杆菌Lactobacillus casei strain Qian工作发酵剂制品及其肠道调节食疗用途
CN105154362A (zh) 一种可预防胃溃疡的发酵乳杆菌Lactobacillus fermentum suo及其保健用途
KR19990007711A (ko) 항 콜레스테롤 유산균을 이용한 기능성 발효유 제조 방법
HK1115067B (en) Immune function modulating agent
HK1115067A1 (en) Immune function modulating agent
TH39459A (th) แลคติคแอซิดแบคทีเรียที่เพิ่มอิมมูนิตี
TH21018B (th) แลคติคแอซิดแบคทีเรียที่เพิ่มอิมมูนิตี

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070412

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101105

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110215

R150 Certificate of patent or registration of utility model

Ref document number: 4688298

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140225

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term